Ruined Olympics

By Felipe Nebesnyj Tue, Jul 20, 2021

Hey Scoopers,

After more concerns about the rise in COVID-19 cases, the markets had their worst day in two months. — More on that in the “Overall Market” section.

Beyond the overall market, a biotech company is confident its vaccine would receive the FDA’s full approval soon. Meanwhile, a tech giant’s investors are not so confident about the analysts’ expectations. — More on that in the “What’s Up?” and “What’s Down?” sections.

By the way, Tokyo doesn’t seem so happy about the Olympics. — More on that in the “Water Cooler” section.

But, first, here is a recap of what happened in the market yesterday:

• U.S. markets: The stock market ended in the red zone on Monday. Scroll down to the “Overall Market” section to read more.
  Cryptocurrency: Bitcoin’s price decreased to $30K per coin.

Last chance to get into the VOMMA Zone…

Wealth is created MUCH faster in times of crisis… like the situation we’re in right now.

And… Don Kaufman believes the current VOMMA Zone is “The Big One” – the Mother of All VOMMA Zones – that can quite possibly create generational, legacy-building wealth for you in the next 18 months… even starting with just a little money.

Click here to discover for yourself how the current VOMMA Zone could create the most prosperous, positive period of time in your life!

(By clicking you agree to receive email updates and special offers from Trader News Media)

COVID Is Not Going Anywhere

The stock market ended in the red zone on Monday.

After growing concerns about inflation and the resurgence of COVID-19 cases, all the three indexes tumbled. The Nasdaq index and the S&P 500 index had their biggest drop in nearly two months. Although the markets had reasonable expectations for earnings reports, jitters over the new COVID-19 variant outweighed everything else.

For Full Approval

So, what happened?

Shares of Ocugen (Ticker: OCGN) were up by more than 12% on Monday. Although the broad market suffered from the infection increase, the significant rise in cases shows the U.S lacks in vaccines. The biotech company is responsible for Covaxin, which is the first COVID vaccine developed in India. And now, Ocugen announced it would target FDA’s full approval for the drug in the U.S. and investors felt excited about the news.

Free – Digital Currency Summit 2021

During the Summit, more than 47 of the world’s top digital currency insiders are gathering for an epic event. Where they will reveal the best investments for the digital currency bull run of 2021. And if you move fast, you can get access for free.

Click here for full details…

Disagreement

So what happened?

Shares of Apple (Ticker: AAPL) were down by more than 2% on Monday. Although many analysts estimate a better-than-expected earnings report from the tech giant, investors raised concerns that the better results might be modest. From the analysts’ perspective, Apple would likely give vague guidelines rather than numerical guidance for the period. Although analysts anticipate great earnings, investors don’t seem to feel so confident about the idea.

Ruined Olympics

So what happened?

After more than a year of postponement, the 2020 Olympics start on Friday in Tokyo. Although long waited, the Olympic games display a reality far from over. The increase in COVID 19 cases led Japan to declare a state of emergency. All spectators were banned, meaning a total of 0 fans attending the event. The pandemic also brought more than $3.3 billion in extra costs for the Tokyo Olympics, a 22% higher-than-expected price to host the games. Although the IOC claims the Olympics are an engine of economic growth and urban revitalization, it seems that Tokyo is far from seeing any economic benefits during the games.

If you have any questions, or suggestions let us know by emailing us at members@tradestocks.com. We look forward to hearing from you.

About the Author

Felipe Nebesnyj is an Economics student who is passionate about the stock market and investing in the market. Originally from Brazil, he is working and studying in the U.S. and started learning about and researching the stock market at 16. Before joining Stock Card, Felipe worked on multiple stock market research projects that gave him the necessary knowledge and confidence to put into his stock market analyst career at Stock Card. Last but not least, he is an excellent violinist and enjoys video games.